1. 2022
  2. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis

    Houttu, V., Bouts, J., Vali, Y., Daams, J., Grefhorst, A., Nieuwdorp, M. & Holleboom, A. G., 3 Nov 2022, In: Frontiers in endocrinology. 13, 1032164.

    Research output: Contribution to journalReview articleAcademicpeer-review

  3. Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for nonalcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar

    Grobbee, E. J., de Jong, V. D., Schrieks, I. C., Tushuizen, M. E., Holleboom, A. G., Tardif, J-C., Lincoff, A. M., Schwartz, G. G., Cabezas, M. C. & Grobbee, D. E., 1 Nov 2022, In: PLoS ONE. 17, 11 November, e0277706.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Microbiome-derived ethanol in nonalcoholic fatty liver disease

    Meijnikman, A. S., Davids, M., Herrema, H., Aydin, O., Tremaroli, V., Rios-Morales, M., Levels, H., Bruin, S., de Brauw, M., Verheij, J., Kemper, M., Holleboom, A. G., Tushuizen, M. E., Schwartz, T. W., Nielsen, J., Brandjes, D., Dirinck, E., Weyler, J., Verrijken, A., de Block, C. E. M., & 7 othersVonghia, L., Francque, S., Beuers, U., Gerdes, V. E. A., Bäckhed, F., Groen, A. K. & Nieuwdorp, M., 1 Oct 2022, In: Nature medicine. 28, 10, p. 2100-2106 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques

    Theel, W., Boxma-de Klerk, B. M., Dirksmeier-Harinck, F., van Rossum, E. F. C., Kanhai, D. A., Apers, J., van Dalen, B. M., de Knegt, R. J., Holleboom, A. G., Tushuizen, M. E., Grobbee, D. E., Wiebolt, J. & Castro Cabezas, M., Aug 2022, In: Obesity reviews. 23, 8, e13481.

    Research output: Contribution to journalReview articleAcademicpeer-review

  6. Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study

    LITMUS Investigators, 1 May 2022, In: Journal of clinical medicine. 11, 10, 2707.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. A non-invasive score for nonalcoholic fatty liver disease (NAFLD) cirrhosis

    van Son, K. C., Tushuizen, M. E., Holleboom, A. G. & Drenth, J. P. H., Apr 2022, In: European journal of internal medicine. 98, p. 43-44 2 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  8. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

    LITMUS Consortium Investigators§, 1 Feb 2022, In: JHEP Reports. 4, 2, 100409.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Defective Lipid Droplet–Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115

    Larsen, L. E., van den Boogert, M. A. W., Rios-Ocampo, W. A., Jansen, J. C., Conlon, D., Chong, P. L. E., Levels, J. H. M., Eilers, R. E., Sachdev, V. V., Zelcer, N., Raabe, T., He, M., Hand, N. J., Drenth, J. P. H., Rader, D. J., Stroes, E. S. G., Lefeber, D. J., Jonker, J. W. & Holleboom, A. G., 1 Jan 2022, In: Cellular and molecular gastroenterology and hepatology. 13, 2, p. 583-597 15 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Noninvasive tests for nonalcoholic fatty liver disease in a multi-ethnic population: The HELIUS study

    van Dijk, A-M., Vali, Y., Mak, A. L., Galenkamp, H., Nieuwdorp, M., van den Born, B-J. & Holleboom, A. G., 2022, (E-pub ahead of print) In: Hepatology communications.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 Next

ID: 5136148